drugset / Trial / NCT03826134
A Positron Emission Tomography (PET) Study to Examine the Brain Binding Properties of a Novel Radioactive Compound [11C]-PXT012253 in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
This study evaluates the usefulness of a PET radioligand to estimate the binding on the mGlu4 receptor in the brain. mGlu4 has been proposed as a therapeutic target in Parkinson's disease.
Timeline
- Start
- 2019-01-17
- Primary completion
- 2019-03-15
- Completion
- 2019-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PXT012253 | Unknown | 5 ug | Intravenous |
| Subject | PXT012253 | Unknown | 400 mbq | Intravenous |